Relaxin-2 (Relaxera)

N/A

Report date: 2026/02/12 20:00:14

Base Information

Drug NameRelaxin-2 (Relaxera)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart FailureAtrial FibrillationArrhythmias, Cardiac +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRelaxera Pharmazeutische Gesellschaft mbH & Co KG
China Registration ClassN/A

Develop Information

Active CompaniesRelaxera Pharmazeutische Gesellschaft mbH & Co KG
Inactive CompaniesN/A
Active IndicationsHeart FailureAtrial FibrillationArrhythmias, Cardiac +[4] 
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A